MDNews - Lower Hudson/Bronx

October 2012

Issue link: https://viewer.e-digitaledition.com/i/86099

Contents of this Issue

Navigation

Page 16 of 43

and diagnostic tests and interventions the patient has undergone previously and their results. The patient's environment at home, school and work is located and any key aspects of those environments that could be negatively contributing to the patient's asthma are also noted. This information is combined with data from the patient's EMR, which is stored in the Montefiore system. The patient then meets with the appropriate allergist and pulmonologist. Should a patient meet with the allergist first, he or she undergoes allergy skin testing. As the test develops, the specialist performs a routine physical and reviews information gathered by the nurse. An additional battery of tests can follow the skin testing, should the patient's case indicate the need for further investiga- tion to identify which allergens provoke the asthma. The allergist then makes recommendations based upon environ- mental and immunological aspects of the disease. "In addition to traditional pharma- cologic approaches to treatment of this disease, we identify candidates for whom immunotherapy and biologic immunomodulators, such as anti-IgE or other recent therapies, would be most helpful," says Deepa Rastogi, M.B.B.S., M.S., attending pulmonologist in respira- tory and sleep medicine at Montefiore and assistant professor of pediatrics Albert Einstein College of Medicne. "There is also a strong emphasis on patient education via collaboration with the specialists and the asthma patient educator to ensure patients are optimally using their preventive medications." The patient then meets with Collado, who begins to develop a supportive relationship by reviewing the physician's recommendations with the patient. She also initiates a strategy for allergen- proofing the patient's environment. These often simple changes may be measures patients aren't sure how to approach, and for pediatric patients, those in which parents should be actively involved, in addition to monitoring changes in routine to help improve their child's asthma. Damaris Collado conducts an asthma education session. ASTHMA IN THE CITY COMBATING ASTHMA IS a challenge for physicians regardless of their geographic or metro- politan locations, says David L. Rosenstreich, M.D., Chief of Allergy and Immunology in the Department of Medicine at Montefiore Medical Center and professor of medicine, microbiol- ogy and immunology, and otorhinolaryngology at Albert Einstein College of Medicine. However, asthma poses a particular obstacle to the medical community in the inner city. The correlation between urban poverty and poor living conditions and hospitalizations and deaths due to asthma was a point of investigation for the National Cooperative Inner-City Asthma Study (NCICAS) in the mid 1990s. The study, which was supported by the National Institute of Allergy and Infectious Diseases, developed into Phase I and Phase II research studies in eight major American cities and was then used as a model for a Centers for Disease Control and Prevention project called the Inner-City Asthma Intervention. In the Phase I trial, the NCICAS tracked 1,528 English-speaking patients and Spanish- speaking patients between the ages of 4 and 9 to identify the factors that increase the incidence of severe asthma episodes. The study revealed that 17% of the sample population did not have asthma medication, 42% of those taking medication received only symptom relief therapies, and while 77% tested positive for one asthma-associated antigen in an allergy skin test, 47% were positive for three or more. The Inner-City Asthma Intervention, whose results were published in the Journal of Pediatrics, revealed additional details about the asthma-related sensitivities in urban areas. Of the metropolitan areas ranked for cockroach, dust and mold prevalence, the Bronx demonstrated the highest — with over 80% of children participating in the study — for cockroach sensitivity. Of the allergens on which the study focused, only the sensitivity and exposure to cockroaches demonstrated increased asthma morbidity.1 The Asthma Center at Montefiore has long-sought to address the rise of asthma in the Bronx. "Asthma prevalence is very high in New York City, and the borough of the Bronx has one of the highest levels in asthma morbidity in the United States," says Sunit Jariwala, M.D., attending allergist in allergy and immunology in the Department of Medicine at Montefiore Medical Center and assistant professor of medicine at Albert Einstein College of Medicine. "Through a multidisciplinary approach, the Asthma Center at Montefiore strives to reduce the growing asthma epidemic in the Bronx." Reference 1. Rosenstreich, D.L., Eggleston, P.E., Kattan, M. et. al.: Role of cockroaches in the asthma morbidity of inner-city children. New England Journal of Medicine, 336:1356-1363; 1997.) MDNEWS.COM ■ MD NEWS Lower Hudson/Bronx | 17

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - October 2012